Cargando…
Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden
For metastases in the central nervous system, angiogenesis enhances metastatic potential and promotes progression. Primary factors which drive vessel growth are vascular endothelial growth factor (VEGF) and angiopoietin-2. Preclinical models show inhibition of either factor reduces metastases spread...
Autores principales: | Bohn, Kaci A., Adkins, Chris E., Nounou, Mohamed I., Lockman, Paul R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387068/ https://www.ncbi.nlm.nih.gov/pubmed/28443023 http://dx.doi.org/10.3389/fphar.2017.00193 |
Ejemplares similares
-
P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
por: Adkins, Chris E., et al.
Publicado: (2013) -
NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer
por: Adkins, Chris E., et al.
Publicado: (2015) -
Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer
por: Terrell-Hall, Tori B., et al.
Publicado: (2017) -
Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease
por: Chugh, Sumant S., et al.
Publicado: (2014) -
Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model
por: Gupta, Parul, et al.
Publicado: (2013)